Benjamin Barwick, PhD, is an Instructor in the Department of Hematology and Medical Oncology as well as a member of the Cell and Molecular Biology Research Program at the Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA. Dr Barwick also holds professional memberships with the American Society of Hematology and American Association of Cancer Research.
Dr Barwick received his PhD in the Genetics and Molecular Biology Program at Emory University School of Medicine in Atlanta, GA. He completed his postdoc training studying multiple myeloma genetics and epigenetics at Winship Cancer Institute of Emory University and earned his MS in bioinformatics at the Georgia Institute of Technology in Atlanta, Georgia.
Speaking on genomic and epigenomic tools to understand disease pathology, therapeutic resistance, and immune responses
Dr Barwick uses his expertise in computational biology to characterize common genomic and epigenomic alterations in the context of disease subtype and patient outcomes. His research investigates cancer-specific alterations using cutting-edge genomic and epigenomic assays coupled with bioinformatic analyses, and functional perturbation using CRISPR-based tools.